These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31392312)

  • 21. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
    Bauersachs R; Wu O; Briere JB; Bowrin K; Borkowska K; Jakubowska A; Taieb V; Toumi M; Huelsebeck M
    Cardiovasc Ther; 2020; 2020():3057168. PubMed ID: 32695228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
    Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
    Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
    Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.
    Hardung D; Behne A; Boral M; Giesche C; Langhoff R
    Dtsch Arztebl Int; 2021 Aug; 118(31-32):528-535. PubMed ID: 33734081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials.
    Tang T; Zhang M; Li W; Hu N; Du X; Ran F; Li X
    Clin Appl Thromb Hemost; 2021; 27():1076029621996810. PubMed ID: 33783251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of DOACs in patients with peripheral arterial disease: A systematic review and meta-analysis.
    Zhang YS; Chen JH; Mei T; Li S; Lu YM
    Vascular; 2021 Dec; 29(6):846-855. PubMed ID: 33504278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial.
    Moll F; Baumgartner I; Jaff M; Nwachuku C; Tangelder M; Ansel G; Adams G; Zeller T; Rundback J; Grosso M; Lin M; Mercur MF; Minar E;
    J Endovasc Ther; 2018 Apr; 25(2):158-168. PubMed ID: 29552984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention-meta-analysis and meta-regression.
    Agarwal N; Mahmoud AN; Mojadidi MK; Golwala H; Elgendy IY
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1134-1139. PubMed ID: 30862490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
    Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
    Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
    Govsyeyev N; Nehler M; Conte MS; Debus S; Chung J; Dorigo W; Gudz I; Krievins D; Mills J; Moll F; Norgren L; Piffaretti G; Powell R; Szalay D; Sillesen H; Wohlauer M; Szarek M; Bauersachs RM; Anand SS; Patel MR; Capell WH; Jaeger N; Hess CN; Muehlhofer E; Haskell LP; Berkowitz SD; Bonaca MP
    J Vasc Surg; 2023 Apr; 77(4):1107-1118.e2. PubMed ID: 36470531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.
    Cho S; Lee YJ; Ko YG; Kang TS; Lim SH; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2359-2370. PubMed ID: 31734299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual versus triple antithrombotic therapy after percutaneous coronary intervention or acute coronary syndrome in patients with indication for anticoagulation: an updated meta-analysis.
    Shin D; Mohanty BD; Lee ES
    Coron Artery Dis; 2018 Dec; 29(8):670-680. PubMed ID: 30222595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
    Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis.
    Galli M; Andreotti F; D'Amario D; Vergallo R; Vescovo GM; Giraldi L; Migliaro S; Ameri P; Porto I; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):43-56. PubMed ID: 31350546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in Antithrombotic Therapy after Infrainguinal Lower Extremity Bypass.
    Brahmandam A; Lee M; Bellamkonda K; Provance JB; Sumpio B; Ochoa Chaar CI; Smolderen KG; Mena-Hurtado C; Guzman RJ
    Ann Vasc Surg; 2023 Jan; 88():51-62. PubMed ID: 36245106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing anticoagulation therapy alone versus anticoagulation plus single antiplatelet drug therapy after transcatheter aortic valve implantation in patients with an indication for anticoagulation: a systematic review and meta-analysis.
    Zhu Y; Meng S; Chen M; Jia R; Nan J; Li H; Zhu H; Li L; Jin Z
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):995-1002. PubMed ID: 33030686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.